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Purpose: Microphthalmia and anophthalmia are at the severe end of the spectrum of abnormalities in ocular development.
A few genes (orthodenticle homeobox 2 [OTX2], retina and anterior neural fold homeobox [RAX], SRY-box 2 [SOX2],
CEH10 homeodomain-containing homolog [CHX10], and growth differentiation factor 6 [GDF6]) have been implicated
mainly in isolated micro/anophthalmia but causative mutations of these genes explain less than a quarter of these
developmental defects. The essential role of the LIM homeobox 2 (LHX2) transcription factor in early eye development
has recently been documented. We postulated that mutations in this gene could lead to micro/anophthalmia, and thus
performed molecular screening of its sequence in patients having micro/anophthalmia.
Methods:  Seventy  patients  having  non-syndromic  forms  of  colobomatous  microphthalmia  (n=25),  isolated
microphthalmia (n=18), or anophthalmia (n=17), and syndromic forms of micro/anophthalmia (n=10) were included in
this study after negative molecular screening for OTX2, RAX, SOX2, and CHX10   mutations.  Mutation  screening   of 
was performed by direct sequencing of the coding sequences and intron/exon boundaries.
Results: Two heterozygous variants of unknown significance (c.128C>G [p.Pro43Arg]; c.776C>A [p.Pro259Gln]) were
identified in LHX2 among the 70 patients. These variations were not identified in a panel of 100 control patients of mixed
origins. The variation c.776C>A (p.Pro259Gln) was considered as non pathogenic by in silico analysis, while the variation
c.128C>G (p.Pro43Arg) considered as deleterious by in silico analysis and was inherited from the asymptomatic father.
Conclusions: Mutations in LHX2 do not represent a frequent cause of micro/anophthalmia.
Microphthalmia and anophthalmia are at the severe end
of the spectrum of abnormalities in ocular development. The
combined  occurrence  rate  for  these  two  malformations  is
estimated between 3 and 30 per 100,000 births [1]. Mutations
in several genes have been found in syndromic and non-
syndromic anophthalmia. Heterozygous mutations in SRY-
box  2  (SOX2)  account  for  approximately  10%  of
anophthalmias [2,3]. Growth differentiation factor 6 (GDF6)
mutations may account for up to 8% of micro/anophthalmia
[4,5]. Other genes have been identified as causing isolated
anophthalmia or microphthalmia in humans (orthodenticle
homeobox  2  [OTX2],  retina  and  anterior  neural  fold
homeobox  [RAX],  and  CEH10  homeodomain-containing
homolog [CHX10]) [1,3,6-8]. These latter are implicated in a
very small proportion of affected individuals, implying wide
genetic heterogeneity to match the phenotypic variability.
The LIM homeobox 2 (LHX2) transcription factor has
been shown to be essential for mammalian eye development
and  mice  deficient  in  functional  Lhx2  protein  have  been
shown to display anophthalmia [9]. More recent studies on
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mouse  models  have  demonstrated  that,  during  eye
development,  Lhx2  regulates  levels  and/or  expression
patterns of Rax, Chx10,  Sox2,  and  Otx2  [10,11],  them-
selves  involved  in human micro/anophthalmia.
We hypothesize that mutations in LHX2 could lead to
severe  eye  developmental  disorders  including  micro/
anophthalmia. We thus performed molecular analysis in 70
micro/anophthalmia patients for whom previous molecular
analysis of genes implicated in isolated micro/anophthalmia
(SOX2,  OTX2,  RAX,  and  CHX10)  failed  to  identify  any
causative mutation.
METHODS
Patients: Seventy patients having non-syndromic forms of
colobomatous  microphthalmia  (n=25),  isolated
microphthalmia  (n=18),  or  anophthalmia  (n=17),  or
syndromic  forms  of  micro/anophthalmia  (n=10)  were
included in this study. Their informed consent was obtained
beforehand, according to French law. Micro/anophthalmia
was considered as syndromic when the patient presents at least
one other non ocular malformation (in our patients, associated
malformations  were  intestinal  atresia  multiple,  corpus
callosum  agenesis,  heart  malformation,  deafness,  Dandy
Walker malformation, labiopalatal cleft, sexual ambiguity,
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LHX2hypospadias, arthrogryposis, and choanal atresia). All patients
included had undergone molecular analysis of SOX2, OTX2,
RAX, CHX10. Direct sequencing of the coding regions and
exon/intron  boundaries  and  exclusion  of  exonic
rearrangement  by  Quantitative  Multiplex  PCR  of  Short
fluorescent  Fragments  (QMPSF)  of  these  genes  failed  to
identify any causative mutation in these patients.
Techniques: The 5 exons of the LHX2 gene were amplified by
PCR  using  primers  deduced  from  the  LHX2  genomic
sequence.  Primer  pairs  and  PCR  conditions  used  are
summarized in Table 1. Products were amplified in 25 µl
reactions containing 50 ng genomic DNA, 1× PCR buffer,
0.2 mM dNTPs, 2 mM MgCl2, 100 nM forward primer, 100
nM reverse primer, and 1 U of Taq polymerase. Betaine (1 M)
was added in PCR mix for exons 1 and 2. All PCR reactions
were performed with a 5 min 95 °C denaturing step, followed
by 14 cycles of 95 °C for 30 s, annealing temperature for 30
s (70 °C to 62 °C, −0.5 °C/cycle) and 72 °C for 45 s, followed
by 20 cycles of 95 °C for 30 s, 62 °C for 30 s, and 72 °C for
45 s with a final elongation step of 72 °C for 7 min. PCR
amplifications were subsequently purified using QIAquick
Gel Extraction kit (QIAGEN SA, Courtaboeuf, France), and
both forward and reverse strands were sequenced using Big
Dye DNA sequencing kit (Applied Biosystems, Warrington,
UK).  Reactions  were  analyzed  in  an  ABI3100  sequencer
(Applied Biosystems). Sequence variations were numbered
with the adenine of the ATG initiation codon as the first
nucleotide  (the  LHX2  GenBank  accession  number  was
NM_004789.3).
RESULTS AND DISCUSSION
LHX2 encodes the transcription factor LHX2 which is highly
conserved  across  species  [12]  and  has  recently  been
demonstrated to play a critical role in eye development [10,
11]. LHX2 is required to induce or maintain expression of
genes  required  at  the  early  optic  vesicle  stage  for
regionalization, establishment of retinal dorsoventral polarity,
retinal progenitor cell properties, and lens specification [11].
LHX2 has thus been proposed to link the multiple pathways
needed for transition of the optic vesicle to the optic cup
[11]. Mice lacking Lhx2 expression display anophthalmia, and
this transcription factor has been involved in regulation of
expression levels and/or expression patterns of genes already
involved  in  micro/anophthalmia  (SOX2,RAX,CHX10,  and
OTX2) during eye development [10,11]. We hypothesized that
mutations  in  LHX2  may  be  involved  in  human  micro/
anophthalmia, and thus molecular screening of this gene in 70
micro/anophthalmic patients was performed.
Molecular  analysis  allowed  identification  of  three
sequence variations. We observed presence of the described
TABLE 1. PRIMERS USED FOR LHX2 MOLECULAR ANALYSIS.
Exon Forward primer Reverse primer Product length (bp)
1 TGAGGCGGGGGGCAAGCCCT GGAGCCACCGGCCTTGCATT 333
2 ATGTCCTGGCAGCCCCCTCC GCCAAACTGTAAGACTGTGCCTG 404
3 CCGTGTGTTCCCACAGCCCC CCGTCGAGGCCGCACACTTT 505
4 TGGGTGGGGCGAGTGTGGAT GTCCTTCCAAGGCCCACGGC 369
5 CTCACCAGCCCTTCCCTGTC ATGTGGTTAGTTAGTTGCTC 445
Figure 1. Missense variations identified in this cohort, and conservation of involved amino-acid among species. Electropherograms showing
the c.128C>G (p.Pro43Arg; A) and the c.776C>A (p.Pro259Gln; 
C
) LHX2 variations. Alignment of part of LHX2 proteins from human,
mouse, Xenopus and zebrafish, showing conservation of proline 43 (
B
, boxed) in these species, and absence of proline 259 conservation (D,
boxed), which is replaced by a glutamine in Xenopus and zebrafish.
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homozygous state in 42 out of 70 patients. In addition, two
variants  of  unknown  significance  were  identified.  The
heterozygous  c.128C>G  (p.Pro43Arg;  Figure  1A)  was
identified in an anophthalmic patient originating from Libya
for  whom  no  other  sequence  variation  was  found.  Pro43
amino-acid is conserved among species (Figure 1C) and is
located closely to the conserved LIM domain 1 of the protein.
This variation was not identified in a panel of 200 control
chromosomes  of  mixed  geographical  origins  (Caucasian,
African,  and  Asian),  and  was  considered  as  probably
damaging by in silico analysis (PolyPhen and SIFT software).
However, familial study has shown that this variation was
inherited  from  his  father  who  harbors  a  normal  ocular
examination. Thus, this heterozygous variation may be non-
pathogenic,  even  if  dominant  inheritance  with  incomplete
penetrance  can  not  be  totally  ruled  out.  We  cannot  also
exclude  presence  of  an  undetected  maternally  inherited
mutation  (e.g  located  in  intronic  or  promoter  region
sequences,  or  an  exonic  rearrangement)  fitting  with  an
autosomal  recessive  inheritance.  In  a  French  patient  with
colobomatous  microphthalmia,  we  identified  the
heterozygous variation c.776C>A (p.Pro259Gln; Figure 1B).
This  variation  was  not  identified  in  a  panel  of  200
chromosomes  from  Caucasian  controls.  No  sample  was
available for his parents, and familial segregation study was
not possible. Additionally, there are arguments against the
implication of this variation in the patient’s ocular phenotype.
First, Pro259 is not a conserved amino-acid among species
(Figure 1D), and a glutamine is present at this position in
several distant species including Xenopus, Chicken, and Fugu
Fish  [12].  Second,  this  variation  was  considered  as  non
damaging by in silico analysis (PolyPhen and SIFT software).
Thus, we consider this variant as probably non deleterious.
Molecular  analysis  failed  to  identify  any  other  sequence
variation in the remaining 68 patients included in this study.
In  conclusion,  although  mutations  in  LHX2  may
nevertheless  be  implicated  in  some  micro/anophthalmia
patients, our results suggest that such sequence variations are
not a frequent cause of micro/anophthalmia. Molecular basis
of these ocular malformations remains still poorly understood
and  further  work  remains  to  be  achieved  to  identify  new
micro/anophthalmia genes.
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